期刊文献+

诺舒阻抗控制系统子宫内膜去除术的临床应用及进展 被引量:17

Clinical Application and Development of NovaSure Impedance Controlled Endometrial Ablation
下载PDF
导出
摘要 异常子宫出血(abnormal uterine bleeding,AUB)是妇科常见病,对于病情严重、药物治疗无效者通常选择子宫切除治疗。子宫内膜去除术(endometrial ablation,EA)通过微创方式破坏子宫内膜,替代子宫切除术,为AUB患者提供了保留子宫的可能。诺舒(NovaSure)阻抗控制系统子宫内膜去除术是第二代子宫内膜去除术之一,在国外已有十余年的应用史,以阻抗控制为原理,利用射频能量将子宫内膜汽化并去除,具有无需术前预处理子宫内膜、自动化操作、平均治疗时间短、不受经期限制、安全性高、疗效显著等特点。 Abnormal uterine bleeding (AUB) is a common problem. Hysterectomy is the standard treatment for those women with heavy menstrual bleeding who have no response to medical treatment. The endometrial ablation (EA) by the minimal invasive procedure to destroy the endometrium has been used to replace hysterectomy. The NovaSure impedance controlled endometrial ablation, one of those minimal invasive procedures, is a second-generation method of EA for clinical practice in foreign countries over decade. Its principle is based on the power delivery and procedure termination concept, and the well-analyzed physical characteristics of tissue (impedance/resistance) allowing for a controlled depth of tissue destruction in an short time. It is not necessary to pre-treat endometrium. Patient can even be treated when actively bleeding. Other benefits for patients are high safety, effective treatment, short operating time, and automatic operation.
出处 《国际生殖健康/计划生育杂志》 CAS 2014年第2期124-127,共4页 Journal of International Reproductive Health/Family Planning
关键词 宫腔镜 宫腔镜检查 子宫出血 诺舒阻抗控制系统 子宫内膜去除术 Hysteroscopes Hysteroscopy Uterine hemorrhage NovaSure impedance controlled system Endometrial ablation
  • 相关文献

参考文献23

  • 1孙小丽,曾俐琴,张华明,陈钰,赵春梅,文斌,蔡怡,罗喜平.诺舒阻抗控制系统治疗月经过多的临床研究[J].中华妇产科杂志,2013,48(1):55-57. 被引量:13
  • 2Gallinat A. An impedance-controlled system for endometrial ablation: five-year follow-up of 107 patients[J]. J Reprod Med, 2007,52( 6 ) : 467-472.
  • 3Fulop T, Rakoczi I, Barna I. NovaSure impedance controlled endometrial ablation: long-term follow-up results[J]. J Minim Invasive Gynecol, 2007,14( 1 ) :85-90.
  • 4Daniels JP, Middleton LJ, Champaneria R, et al. Second generation endometrial ablation techniques for heavy menstrual bleeding: network meta-analysis[J]. BMJ, 2012,344: e2564.
  • 5Cooper J, Gimpelson RJ. Sufiamary of safety and effectiveness data from FDA: a valuable source of information on the performance of global endometrial ablation devices[J]. J Reprod Meal,2004,49(4) : 267-273.
  • 6Sabbab R, Desaulniers G. Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intraeavitary disease: 12-month follow-up results of a prospective, single-arm clinical study[J]. J Minim Invasive Gynecol, 2006,13 (5) : 467-471.
  • 7Fakih M, Cherfan V, Abdallah E. Success rate, quality of life, and descriptive analysis after generalized endometrial ablation in an obese population [J]. Int J Gynaecol Obstet, 2011,113 ( 1 ) : 120 - 123.
  • 8Kleijn JH, Engels R, Bourdrez P,et al. Five-year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation[J]. BJOG,2008,115(2) : 193-198.
  • 9Potti S,Uppal S,Chatwani AJ,et al. Novasure as a mechanical endometrial preparation agent in large uteri[J]. JSLS, 2012,16(4): 537-541.
  • 10Khan Z,E1-Nashar SA,Hopkins MR,et al. Efficacy and safety of global endometrial ablation after cesarean delivery: a cohort study [J]. Am J Obstet Gyneeo1,2011,205(5 ) :450 e1-4.

二级参考文献22

  • 1冯缵冲 邵敬於.实用官腔镜学[M].上海:上海医科大学出版社,1999.47.
  • 2Dequesne JH, Gallinat A, Gm-za - Leal JG, et al. Thermo- regulated radiofrequency cndometrtrial ablation[J]. Int J Fertil Women Med,1997,42(5) :311.
  • 3Medical Date International, Inc. Gynecological surgery [J]. MedPro Month, 1997.
  • 4Loffer FD. Three - year comparison of thermal balloon and rollerball ablation in treatment of menorrhagia [J]. J Am Assoc Gynecol Laparosc 2001,8( 1 ) :48.
  • 5Corson SL A multicenter evaluation of endometrial ablation by hydro thermablator and roUerball for treatment of menorrhagia.[J]. J Am Assoc Gynecol Laparosc 2001,8(3) :359.
  • 6Hulka JF, Peterson HA, Phillips JM, et aL Operative hyste- roscopy:American Association of Gynecologic Laparoscopists 1991 membership survey[J]. J Reprod Med,1993,38(8) :572.
  • 7Laberge PY, Sabbah R, Fortin C, Gallinat A. Assessment and comparison of intra and postoperative pain associated with No- vasure and ThermaChoice endometrial ablation systems[J]. J Am Assoc Gynecol Lapamsc,2003,10(2) :223.
  • 8Cooper J, Gimpelson R Summary of safety and effective- hess data(SSED) from FDA:a valuable source of information on the performance of global endometrial ablation devices[J]. J Re- prod Med,2004,49(4) :267.
  • 9Cooper J,Gimpleson R,Laberge P,et aLA randomized, multieenter trial of safety and efficacy, of the Nova.Sure System in the treatment of menorrhagia [J]. J Am Assoe Gyneeol Lalmrmc, 2002,9(4) :418.
  • 10Harzad report. Incorrect measurement of ttlerine cavity while using Hologic NovaSure endometrial ablation system can re- suit in patient injury[J]. Health Devices,2009,38(9) :302.

共引文献20

同被引文献105

  • 1张福云,王文华,刘婷,曾华,胡萍,吴名桃.诺舒治疗无生育要求的异常子宫出血临床研究[J].医学信息,2017,30(4):55-56. 被引量:2
  • 2WuJi,Ling-TangLi,Zhi-MingWang,Zhu-FuQuan,Xun-RuChen,Jie-ShouLi.A randomized controlled trial of laparoscopic versus open cholecystectomy in patients with cirrhotic portal hypertension[J].World Journal of Gastroenterology,2005,11(16):2513-2517. 被引量:23
  • 3张喜锐,赵莉,杨晓敏,陈海英.心理干预、健康教育预防股骨颈骨折患者术后并发症临床观察[J].陕西医学杂志,2006,35(7):901-901. 被引量:6
  • 4Munro MG, Critehley HO, Fraser IS, et al. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years[J]. Fertil Steril,2011,95 (7) :2204-2208.
  • 5Gallinat A. An impedance-controlled system for endometrial ablation: five-year follow-up of 107 patients[J]. J Reprod Med, 2007,52 (6) : 467- 472.
  • 6Kleijn JH, Engels R, Bourdrez P, et al. Five-year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation[J]. BJOG, 2008,115(2) : 193-198.
  • 7Kalkat RK, Cartmill RS. NovaSure endometrial ablation under local anaesthesia in an outpatient setting: an observational study[J]. J Obstet Gynaecol, 2011,31(2) : 152-155.
  • 8Asgari Z, Moini A, Samiee H, et al. Endometrial ablation with the NovaSure system in Iran[J]. Int J Gyn.aeeol Obstet, 2011,114(1) : 73- 75.
  • 9Baskett TF, Clough H, Scott TA. NovaSure bipolar radiofrequency endometrial ablation: report of 200 cases[J]. J Obstet Gynaecol Can, 2005,27(5) :473-476.
  • 10Cooper J ,Gimpelson RJ. Summary of safety and effectiveness data from FDA, a valuable source of information on the performance of global endometrial ablation devices[J]. J Reprod Med, 200:, 49 (4) : 267-273.

引证文献17

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部